NESTE:OMXHEXNeste Corporation Analysis

Technical momentum remains robust as the price of €27.2 sits above the 20‑day (≈22.9), 50‑day (≈21.6) and 200‑day (≈16.9) SMAs, and the MACD histogram is positive, indicating a bullish signal. However, the RSI at 75 points to an overbought condition and the stock is flirting with the resistance level of €28.04.
Valuation mismatch is stark: a discounted cash‑flow fair value of roughly €4.8 versus the current market price signals severe overvaluation, while the trailing P/E of 151 collapses to a forward P/E of 17.6, reflecting expected earnings recovery. The dividend payout ratio exceeds 100% and the yield is modest at 0.72%, raising doubts about dividend sustainability. Fundamentally, revenue declined 11% and margins are thin (gross ~13%, profit
Risk profile shows high price volatility (~50% 30‑day) but a low beta (~0.2), suggesting limited market‑wide systematic risk yet the potential for large price swings. Combined with sector transition pressures, the overall risk is moderate.